Enzymatically synthesized 2′-fluoro-modified Dicer-substrate siRNA swarms against herpes simplex virus demonstrate enhanced antiviral efficacy and low cytotoxicity-Reference-Cited by-同舟云学术

Enzymatically synthesized 2′-fluoro-modified Dicer-substrate siRNA swarms against herpes simplex virus demonstrate enhanced antiviral efficacy and low cytotoxicity

Published:2020-10 Issue: Volume:182 Page:104916
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Levanova Alesia A.^ORCID,Kalke Kiira M.^ORCID,Lund Liisa M.^ORCID,Sipari Nina^ORCID,Sadeghi Mohammadreza,Nyman Marie C.,Paavilainen Henrik,Hukkanen Veijo,Poranen Minna M.^ORCID

Funder

Jane and Aatos Erkko Foundation

Sigrid Jusélius Foundation

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference32 articles.

1. RNA interference in mammalian cells by chemically-modified RNA;Braasch;Biochemistry,2003

2. Chemical modification of siRNAs to improve serum stability without loss of efficacy;Choung;Biochem. Biophys. Res. Commun.,2006

3. Bovine pancreatic ribonuclease: fifty years of the first enzymatic reaction mechanism;Cuchillo;Biochemistry,2011

4. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells;Czauderna;Nucleic Acids Res.,2003

5. Off-target effects by siRNA can induce toxic phenotype;Fedorov;RNA,2006

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flexible nano-liposomes-encapsulated recombinant UL8-siRNA (r/si-UL8) based on bioengineering strategy inhibits herpes simplex virus-1 infection;Antiviral Research;2024-08

2. Chemically Modified Platforms for Better RNA Therapeutics;Chemical Reviews;2024-01-29

3. Utilization of Bacteriophage phi6 for the Production of High-Quality Double-Stranded RNA Molecules;Viruses;2024-01-22

4. Diversity and Current Classification of dsRNA Bacteriophages;Viruses;2023-10-25

5. Single therapeutic dose of an antiviral UL29 siRNA swarm diminishes symptoms and viral load of mice infected intranasally with HSV‐1;Smart Medicine;2023-05